PAK4 inhibition augments anti-tumour effect by immunomodulation in oral squamous cell carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
PAK4 inhibition augments anti-tumour effect by immunomodulation in oral squamous cell carcinoma ; volume:14 ; number:1 ; day:18 ; month:6 ; year:2024 ; pages:1-14 ; date:12.2024
Scientific reports ; 14, Heft 1 (18.6.2024), 1-14, 12.2024
- Creator
-
Takatsuka, Danki
Tachinami, Hidetake
Suzuki, Nihei
Yamazaki, Manabu
Yonesi, Amirmoezz
Takaichi, Mayu
Imaue, Shuichi
Yamada, Shin-Ichi
Tanuma, Jun-Ichi
Noguchi, Makoto
Tomihara, Kei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-64126-0
- URN
-
urn:nbn:de:101:1-2409110947587.275173408011
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Takatsuka, Danki
- Tachinami, Hidetake
- Suzuki, Nihei
- Yamazaki, Manabu
- Yonesi, Amirmoezz
- Takaichi, Mayu
- Imaue, Shuichi
- Yamada, Shin-Ichi
- Tanuma, Jun-Ichi
- Noguchi, Makoto
- Tomihara, Kei
- SpringerLink (Online service)
Other Objects (12)
Acid affairs in anti-tumour immunity
Anti-tumour activity of Panobinostat in oesophageal adenocarcinoma and squamous cell carcinoma cell lines
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Glutarate regulates T cell metabolism and anti-tumour immunity
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy
A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer
Acid affairs in anti-tumour immunity
Anti-tumour activity of Panobinostat in oesophageal adenocarcinoma and squamous cell carcinoma cell lines
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Glutarate regulates T cell metabolism and anti-tumour immunity
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy
A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer
Acid affairs in anti-tumour immunity
Anti-tumour activity of Panobinostat in oesophageal adenocarcinoma and squamous cell carcinoma cell lines
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Glutarate regulates T cell metabolism and anti-tumour immunity
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy